Free Newsletter
Vaccines critical for controlling chronic diseases
Vaccines are a vital part of controlling non-communicable diseases (NCDs) around the world, even though most shots are designed to prevent illnesses that can be passed from person-to-person. That's according to health experts who spoke at a recent U.N. General Assembly summit on NCDs.
"A number of what we call NCDs turn out to be infectious diseases. About 20% of cancer is actually caused by infectious agents. We've had a lot of success getting rid of hepatitis B, which is the largest cause of liver cancer and we are hoping with the...[HPV vaccine] to be able to get rid of cervical cancer," noted GAVI Alliance CEO Seth Berkley. Increased vaccine access worldwide is one way to prevent many NCDs, but other risk factors--like obesity, heart conditions, diabetes and many cancers--will have to be dealt with in other ways.
- read the article for more
PLUS: Every year more than 2 million kids die before the age of 5 due to vaccine-preventable diseases. In an effort to further protect children from preventable diseases (and, in the long run, NCDs) the GAVI Alliance announced this week it would commit $3.4 billion over the next four years for rotavirus and pneumonia vaccines for children in 37 developing countries. Of the countries targeted by the funding, two dozen are in Africa. News
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: